| Future Health Pharma GmbH - Buvidal 16 mg, Depot-Injektionslösung |
| 67941 | | 02 | | Buvidal 16 mg | | Depot-Injektionslösung | | N07BC01 | | Buprenorphine | | 17.12.2020 | | |
|
| Composition |
| buprenorphinum 16 mg, ethanolum anhydricum 30.62 mg, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.32 ml. |
| Packungsbestandteile |
| Depot-Injektionslösung | | | | | | | | Active Agent | Dose |
|---|
| Buprenorphine | 16mg / 0.32ml |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphine | 16 mg |
| | | | Inactive agents | Dose |
|---|
| Ethanol Anhydrate | 30.62mg / 0.32ml | | Glyceroli Dioleas | | | Phosphatidylcholinum ex Soja | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | | 54.96 | 76.20 | A+ | SL | No |
|
